PRPH2 and retinal degeneration: An AAV vector was first reported to be successful for the treatment of a preclinical model of IRD in 1998, when it was used to restore visual function in the retinal degeneration slow (rds) mouse through the reintroduction of a wild-type copy of the PRPH2 gene [107].